GlassScriptPhysician profile
Taylor Weidman
NPI 1649702499
$6,338.84
in general payments reported to CMS, 2019-2025
19 companies · $1,690 in 2025
The $1,690 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $33.38 · 2021: $528 · 2022: $2,916 · 2023: $743 · 2024: $328 · 2025: $1,690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,186 · Education: $1,000 · Travel and Lodging: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.01 |
| Education | $1,000.00 |
| Travel and Lodging | $574.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,771.50 | 2021-2025 | |
| Hologic Sales and Service, LLC | $596.86 | 2022-2024 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Aspira Women'S Health INC | $562.22 | 2021-2023 | Ova1 |
| Sumitomo Pharma America, INC. | $278.53 | 2023-2024 | Myfembree |
| Abbvie INC. | $208.52 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Coopersurgical, INC. | $192.55 | 2021-2023 | Summit Doppler, Paragard T 380a |
| Organon LLC | $152.88 | 2022-2024 | Nexplanon |
| Astellas Pharma US INC | $150.63 | 2023-2024 | Veozah |
| Myovant Sciences INC. | $109.62 | 2022 | |
| Therapeuticsmd, INC. | $101.58 | 2021-2022 | |
| Ethicon US, LLC | $44.09 | 2024 | Vistaseal, Enseal, Stratafix |
| Pfizer INC. | $40.87 | 2022 | |
| Merck Sharp & Dohme LLC | $28.22 | 2020-2023 | Gardasil 9 |
| Avanos Medical | $21.82 | 2021 | |
| Biogen, INC. | $20.22 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $17.22 | 2023 | Axonics, Bulkamid |
| Mayne Pharma Commercial LLC | $15.41 | 2023 | |
| Medicem INC. | $14.18 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Weidman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.